Here are relevant reports on : lab-glassware-market
-
Drug Discovery Technologies Market by Product (Instruments, Reagents, Software), Technology (HTS, NGS, PCR, AI-based, Lab-on-chip), Process (Target Identification, Validation, Lead Optimization), Therapeutic Area (Oncology, CVD) - Global Forecast to 2030
The Drug Discovery Technologies market, valued at US$28.61 billion in 2024, stood at US$30.58 billion in 2025 and is projected to advance at a resilient CAGR of 11.0% from 2025 to 2030, culminating in a forecasted valuation of US$51.51 billion by the end of the period. The growth of the drug discovery technologies market is driven by the broader use of advanced screening platforms and rising demand for biologics, cell and gene therapies, and RNA-based drugs.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Agriculture Biotechnology Market (Agriculture-Themed Microarrays Lab-on-Chip Devices RNA Interference Assays, Agriculture-Derived Biofuels Chemicals Transgenic Seeds) - 2018 By Application & Geography
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Lab Accessories Market by Type (Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station) & End User (OEM/Biotechnology & Pharmaceutical Companies/Hospital/Private Labs/Research Institute) - Global Forecast to 2020
The laboratory accessories market is valued at $327.0 million in 2014. It is expected to reach $504.7 million by 2020, growing at a CAGR of 7.5% from 2014 to 2020. The laboratory accessories market is dominated by North America, it is followed by Europe, Asia and Rest of the world. The Asian market is the fastest growing in the forecast period (2014-2020). Reagent reservoirs is the fastest-growing segment of this market.
- Published: March 2015
- Price: $ 4950
- TOC Available:
-
Protein Assays Market by Product (Reagent, Kit, Instruments), Type (Dye Binding, Test Strip), Application (Drug Discovery, Disease Diagnosis), Technology (Colorimetric, Fluorescence), End User (Pharmaceutical, Clinical Lab) - Global Forecasts to 2022
The protein assays market is projected to reach USD 2.41 Billion by 2022, at a CAGR of 11.1%. Some of the prominent players in the market are Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Merck KGaA (Germany), Cell Signaling Technology, Inc. (U.S.), General Electric Company (U.S.), and PerkinElmer Inc. (U.S.).
- Published: May 2017
- Price: $ 4950
- TOC Available:
-
Agriculture Biotechnology Market (Agriculture-Themed Microarrays Lab-on-Chip Devices RNA Interference Assays, Agriculture-Derived Biofuels Chemicals Transgenic Seeds) - 2018 By Application & Geography
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Clinical Communication & Collaboration Market By Platform (Voice, Messaging), Component (Badge, Nurse Call, VOIP, Wearable, Alert, Scheduling, Telehealth), Application (Nurse, Lab/Radiology, Patient), End User (Hospitals, ASC) - Global Forecast to 2030
The global clinical communication & collaboration market, valued at US$2,598.1 million in 2024, stood at US$2,876.1 million in 2025 and is projected to advance at a resilient CAGR of 13.02% from 2025 to 2030, culminating in a forecasted valuation of US$5,302.9 million by the end of the period. The clinical communication and collaboration market is experiencing rapid growth, driven by the increasing need for real-time communication and effective care coordination.
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
Central Lab Services/Clinical Trial Lab Services Market by Phase (Phase I, II, III), Service Type (Safety Testing, Immunology), Therapeutic Area (Oncology), Modality (Small Molecules, Vaccine), End user (Pharma & CROs) & Region - Global Forecast to 2030
The global central lab services/clinical trial lab services market, valued at US$5.64 billion in 2024, stood at US$5.97 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a forecasted valuation of US$8.18 billion by the end of the period. The growth of the Asia Pacific central lab services/clinical trial lab services market can be attributed to the increasing prevalence of chronic diseases, such as cancer, kidney diseases, and CVDs.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Molecular Diagnostics Market by Product & Service (Kits, Instruments, Software), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), and Application (Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)) - Global Forecast to 2030
The global molecular diagnostics market, valued at USD 18.29 billion in 2024, stood at USD 19.48 billion in 2025 and is projected to advance at a resilient CAGR of 9.6% from 2025 to 2030, culminating in a forecasted valuation of USD 30.74 billion by the end of the period. The Asia Pacific market is projected to register the highest CAGR during the forecast period, primarily due to the increasing healthcare expenditure and rapid expansion of medical infrastructure in Asia Pacific countries.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Protein A Resin Market by Product (Bulk Resin, Lab-scale Columns), Source (Recombinant Protein A), Matrix Type (Agarose-Based Protein A), Application (Monoclonal Antibody Purification, FC-Fusion Protein Purification) & End User - Global Forecast to 2030
The global protein A resin market, valued at US$1.4 billion in 2024, stood at US$1.5 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a forecasted valuation of US$2.0 billion by the end of the period. The market's growth is connected to increased outsourced services through CDMOs, as major companies expand multi-plant biomanufacturing capacities in developed markets.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Bioreactors Market by Scale Range (20L, 1500L), Material (Single-Use, Stainless Steel), Usage (Lab Scale, Pilot Scale, Full Scale), Suppliers (OEMs, EPCs), End-User (R&D Departments, Biopharmaceutical Manufacturers), Region- Global Forecast to 2021
The global bioreactors market size is projected to grow at a CAGR of 6.8%. The increase in adoption of single-use technologies, use of hybrid technologies: single-use and stainless steel, growing popularity of single-use bioreactor among biopharmaceutical companies, and growing biologics are spurring the growth of the bioreactors market. However, regulatory concerns related to single-use bioreactors, issues regarding leachable and extractable related to single-use bags is hampering the growth of this market.
- Published: September 2016
- Price: $ 18000
- TOC Available:
Records 21 to 30 of 50
